Investigation of the biodistribution and dosimetry for combined Lu-177/Ac225-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging

被引：0
|
作者：
Delker, A. [1 ]
Schleske, M. [1 ]
Liubchenko, G. [1 ]
Berg, I. [1 ]
Zacherl, M. J. [1 ]
Brendel, M. [1 ]
Gildehaus, F. J. [1 ]
Harbach, A. [1 ]
Rumiantcev, M. [1 ]
Resch, S. [1 ]
Kaiser, L. [1 ]
Brosch-Lenz, J. [1 ]
Wenter, V. [1 ]
Unterrainer, L. [1 ]
Bartenstein, P. [1 ]
Ziegler, S. [1 ]
Beyer, L. [1 ]
Boning, G. [1 ]
机构：
[1] LMU Hosp, Dept Nucl Med, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-374
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 33 条
  • [21] Influence of a late SPECT/CT acquisition and the selected fit model on lesion dosimetry for Lu-177-PSMA-I&T therapy in the context of clinical routine
    Resch, S.
    Fouladgar, S. L. Takayama
    Sheikh, G.
    Liubchenko, G.
    Rumiantcev, M.
    Zacherl, M.
    Wenter, V.
    Bartenstein, P.
    Ziegler, S.
    Ilhan, H.
    Beyer, L.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S643 - S643
  • [22] Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapy using Deep Learning
    Xue, Song
    Gafita, Andrei
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Rominger, Axel
    Shi, Kuangyu
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [23] Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, Nahid
    Wurzer, Alexander
    Herz, Michael
    D'Alessandria, Calogero
    Feuerecker, Benedikt
    Weber, Wolfgang
    Wester, Hans-Juergen
    Nekolla, Stephan
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1106 - 1111
  • [24] Comparison of absorbed dose to kidneys using quantitative SPECT/CT and whole body planar images for 177Lu-PSMA I&T in prostate cancer therapy
    Ghodoosi, E. Karimi
    D'Alessandria, C.
    Eiber, M.
    Li, W.
    Navab, N.
    Ziegler, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S112 - S113
  • [25] Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity?
    Langbein, T.
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Zhang, J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S645 - S645
  • [26] Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity?
    Langbein, Thomas
    Kulkarni, Harshad
    Singh, Aviral
    Schuchardt, Christiane
    Zhang, Jingjing
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [27] Radioligand therapy using combination of Ac-225 and Lu-177 labelled PSMA ligands for progressive end-stage metastatic prostate cancer: effective trade-off between response and toxicity
    Kulkarni, Harshad
    Zhang, Jingjing
    Langbein, Thomas
    Schuchardt, Christiane
    Singh, Aviral
    Mueller, Dirk
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [28] Investigation of influencing factors on the yield of double-strand-breaks and the relative biological effectiveness of Ac-225-PSMA and Lu-177-PSMA therapy using TOPAS-nBio particle track structure simulations
    Rumiantcev, M.
    Li, W. B.
    Lindner, S.
    Liubchenko, G.
    Resch, S.
    Bartenstein, P.
    Beyer, L.
    Ziegler, S.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S391 - S392
  • [29] Automatic image segmentation for 3D dosimetry in Lu-177 DKFZ-PSMA-617 therapy of castrate-resistant metastatic prostate cancer using a robust cluster algorithm on 4D SPECT data
    Vomacka, Lena
    Gosewisch, Astrid
    Delker, Andreas
    Fendler, Wolfgang
    Bartenstein, Peter
    Boening, Guido
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [30] Radiation Toxicity Concerning Salivary and Lachrymal Glands Caused by Peptide Radioligand Therapy Using a Lu-177 PSMA Inhibitor (I&T) in Patients with Metastasized Prostate Cancer: First in Human Studies
    Ozkan, A.
    Schuchardt, C.
    Kulkarni, H.
    Shahinfar, M.
    Sayeg, M.
    Baum, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S337 - S338
1234